Immunologic, virologic and drug resistance outcomes in an HIV-infected prospective cohort on treatment in South Africa
The UNAIDS target of 95% viral suppression in individuals under treatment was not observed after 12 months of treatment, and this was less successful for males. Adherence and drug resistance monitoring could be beneficial for individuals harbouring resistant viruses early into treatment.
Authors
- Denis M. Tebit (ORCID: https://orcid.org/0000-0002-4540-6245)
- Lufuno Grace Mavhandu-Ramarumo (ORCID: https://orcid.org/0000-0001-7585-5036)
- Bixa Ogola (ORCID: https://orcid.org/0000-0002-0744-0602)
- Pascal Bessong (ORCID: https://orcid.org/0000-0003-0561-272X)
- Nontokozo D. Matume (ORCID: https://orcid.org/0000-0003-3766-5463)
Institutions
- Center for Global Health (US)
- University of Virginia (US)
- University of Venda (ZA)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1371/journal.pone.0307519
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- South African Medical Research Council
- Medical Research Council